CAS NO: | 1338934-59-0 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 |
MKC8866, a salicylaldehyde analog, is a potent, selectiveIRE1RNaseinhibitor with anIC50of 0.29 μM in human vitro. MKC8866 strongly inhibits Dithiothreitol-induced X-box-binding protein 1-spliced (XBP1s) expression with anEC50of 0.52 μM and unstresses RPMI 8226 cells with an IC50of 0.14 μM[1]. MKC8866 inhibitsIRE1RNase in breastcancercells leading to the decreased production of pro-tumorigenic factors and it can inhibits prostatecancer(PCa) tumor growth[2]. |
||||||||||||||||||||||||||||||||
IC50& Target |
IC50: 0.29 μM (IRE1 RNase)[1] |
||||||||||||||||||||||||||||||||
体外研究 (In Vitro) |
MKC8866 (20 μM; 6 days) decreases proliferation of all breast cancer cell lines[2].
Cell Proliferation Assay[2]
Cell Cycle Analysis[2]
Cell Cycle Analysis[1]
Cell Cycle Analysis[2]
|
||||||||||||||||||||||||||||||||
体内研究 (In Vivo) |
MKC8866 (oral ; 300 mg/kg; for 28 days) reduces tumor regrowth post-NSC 125973 withdrawal[1].
|
||||||||||||||||||||||||||||||||
分子量 |
361.35 |
||||||||||||||||||||||||||||||||
性状 |
Solid |
||||||||||||||||||||||||||||||||
Formula |
C18H19NO7 |
||||||||||||||||||||||||||||||||
CAS 号 |
1338934-59-0 |
||||||||||||||||||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||||||||||||||||||
储存方式 |
|
||||||||||||||||||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 16.67 mg/mL(46.13 mM;Need ultrasonic)
配制储备液
*
请根据半岛bd体育手机客户端 在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的半岛bd体育手机客户端 失效。
In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
*
以上所有助溶剂都可在本网站选购。
|